Risk Communication Advisory Committee

This article was originally published in The Tan Sheet

11 Jun 2007

Executive Summary

FDA is requesting nominations for membership to its new advisory committee. Comprising 15 voting members, the committee will advise the agency on ways to better communicate the risks and benefits of FDA-regulated products. FDA formed the advisory group in response to recommendations by the Institute of Medicine's 2006 report, "The Future of Drug Safety: Promoting and Protecting the Health of the Public"...

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

Subjects
OTC Drugs

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

OTC Drugs

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS100602

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS100602

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Risk Communication Advisory Committee

Executive Summary

Related Content

FDA Risk Communication Panel’s Charter Is Tweaked As Members Are Named

Topics

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert